A benign vascular tumor with a new fusion gene: EWSR1-NFATC1 in hemangioma of the bone

American Journal of Surgical Pathology

Volumn 37, Issue 4, 2013, Pages 613-616

  Arbajian, Elsa ^a   Magnusson, Linda ^a   Brosjö, Otte ^b   Wejde, Johan ^c   Folpe, Andrew L ^d   Nord, Karolin H ^a   Mertens, Fredrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Department of Orthopedics ^*  (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d MAYO CLINIC   (United States)

Author keywords

EWSR1; gene fusion; hemangioma of bone; NFATC1

Indexed keywords

CALMODULIN BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; NFATC1 PROTEIN, HUMAN; ONCOPROTEIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT;

ADULT; ARTICLE; BONE TUMOR; CASE REPORT; CHROMOSOME 22; CHROMOSOME BANDING PATTERN; DISEASE FREE SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HEMANGIOMA; HUMAN; MALE; OCCIPITAL BONE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BONE NEOPLASMS; CALMODULIN-BINDING PROTEINS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 22; DISEASE-FREE SURVIVAL; HEMANGIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NFATC TRANSCRIPTION FACTORS; OCCIPITAL BONE; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 84875127366     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31827ae13b     Document Type: Article

References (20)

1. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007;7: 233-245.
2. Riggi N, Cironi L, Suva ML, et al. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol. 2007;213:4-20.
3. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162-165.
4. Mitelman F, Johansson B and Mertens F (Eds). Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer 2012. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed September 3, 2012.
5. MayWA, Lessnick SL, Braun BS, et al. The Ewing's sarcoma EWS/ FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol. 1993;13:7393-7398.
6. Bailly RA, Bosselut R, Zucman J, et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol. 1994;14:3230-3241.
7. Adler CP, Wold L. Haemangiomas and related lesions. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. . Lyon: IARC Press; 2002:320-321.
8. Hung CT, Jou IM, Huang MT. Intraosseous capillary haemangioma of a metacarpal bone. J Hand Surg Eur. 2012;37:76-77.
9. Mandahl N. Methods in solid tumor cytogenetics. In: Rooney D, ed. Methods in Solid Tumor Cytogenetics. 3rd ed. New York: New York University Press; 2001:165-203.
10. Shaffer LG, Slovak ML, Campbell LJ. An International System for Human Cytogenetic Nomenclature. Basel: Karger; 2009.
11. Jin Y, Mo ller E, Nord KH, et al. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer. 2012;51:510-520.
12. Panagopoulos I, Mertens F, Domanski HA, et al. No EWS/FLI1 fusion transcripts in giant-cell tumors of bone. Int J Cancer. 2001;93:769-772.
13. Mandahl N, Jin Y, Heim S, et al. Trisomy 5 and loss of the Y chromosome as the sole cytogenetic anomalies in a cavernous hemangioma/angiosarcoma. Genes Chromosomes Cancer. 1990;1: 315-316.
14. Mo ller E, Stenman G, Mandahl N, et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol. 2008;215:78-86.
15. Hogan PG, Chen L, Nardone J, et al. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17:2205-2232.
16. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5:472-484.
17. Szuhai K, Ijszenga M, de Jong D, et al. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res. 2009;15:2259-2268.
18. Sankar S, Lessnick SL. Promiscuous partnerships in Ewing's sarcoma. Cancer Genet. 2011;204:351-365.
19. Panagopoulos I, Mertens F, Isaksson M, et al. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 2002;35:340-352.
20. Debelenko LV, McGregor LM, Shivakumar BR, et al. A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma. Genes Chromosomes Cancer. 2011;50:1054-1062.